These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 25868557)

  • 21. Novel metabolites of buprenorphine detected in human liver microsomes and human urine.
    Chang Y; Moody DE; McCance-Katz EF
    Drug Metab Dispos; 2006 Mar; 34(3):440-8. PubMed ID: 16381669
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In Vitro Inhibitory Effects of Synthetic Cannabinoid EAM-2201 on Cytochrome P450 and UDP-Glucuronosyltransferase Enzyme Activities in Human Liver Microsomes.
    Kong TY; Kwon SS; Cheong JC; Kim HS; Kim JY; Lee HS
    Molecules; 2018 Apr; 23(4):. PubMed ID: 29659506
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The cytochrome P450-catalyzed metabolism of levomepromazine: a phenothiazine neuroleptic with a wide spectrum of clinical application.
    Wójcikowski J; Basińska A; Daniel WA
    Biochem Pharmacol; 2014 Jul; 90(2):188-95. PubMed ID: 24841887
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interaction of buprenorphine and its metabolite norbuprenorphine with cytochromes p450 in vitro.
    Zhang W; Ramamoorthy Y; Tyndale RF; Sellers EM
    Drug Metab Dispos; 2003 Jun; 31(6):768-72. PubMed ID: 12756210
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of voriconazole and other azole antifungal agents on CYP3A activity and metabolism of tacrolimus in human liver microsomes.
    Zhang S; Pillai VC; Mada SR; Strom S; Venkataramanan R
    Xenobiotica; 2012 May; 42(5):409-16. PubMed ID: 22106961
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of human cytochrome P450s involved in the formation of all-trans-retinoic acid principal metabolites.
    Marill J; Cresteil T; Lanotte M; Chabot GG
    Mol Pharmacol; 2000 Dec; 58(6):1341-8. PubMed ID: 11093772
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of the human liver microsomal cytochrome P450s involved in the metabolism of N-nitrosodi-n-propylamine.
    Teiber JF; Hollenberg PF
    Carcinogenesis; 2000 Aug; 21(8):1559-66. PubMed ID: 10910959
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The impact of azole antifungal drugs on imatinib metabolism in human liver microsomes.
    Luo X; Li T; Yu Z; Xue X; Zhao H; Li N; Ma L; Yang C; Huang L; Feng W
    Xenobiotica; 2019 Jul; 49(7):753-761. PubMed ID: 29770723
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of benzodiazepines on the metabolism of buprenorphine in human liver microsomes.
    Chang Y; Moody DE
    Eur J Clin Pharmacol; 2005 Feb; 60(12):875-81. PubMed ID: 15657781
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cytochrome P450-mediated metabolism of the synthetic cannabinoids UR-144 and XLR-11.
    Nielsen LM; Holm NB; Olsen L; Linnet K
    Drug Test Anal; 2016 Aug; 8(8):792-800. PubMed ID: 26360322
    [TBL] [Abstract][Full Text] [Related]  

  • 31.
    Xu S; Zhang F; Chen D; Su K; Zhang L; Jiang R
    Pharm Biol; 2020 Dec; 58(1):308-313. PubMed ID: 32285742
    [No Abstract]   [Full Text] [Related]  

  • 32. The biotransformation of clomipramine in vitro, identification of the cytochrome P450s responsible for the separate metabolic pathways.
    Nielsen KK; Flinois JP; Beaune P; Brøsen K
    J Pharmacol Exp Ther; 1996 Jun; 277(3):1659-64. PubMed ID: 8667235
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Determination of oxycodone, noroxycodone and oxymorphone by high-performance liquid chromatography-electrospray ionization-tandem mass spectrometry in human matrices: in vivo and in vitro applications.
    Fang WB; Lofwall MR; Walsh SL; Moody DE
    J Anal Toxicol; 2013; 37(6):337-44. PubMed ID: 23743505
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro inhibitory effects of Friedelin on human liver cytochrome P450 enzymes.
    Wei J; Zhang H; Zhao Q
    Pharm Biol; 2018 Dec; 56(1):363-367. PubMed ID: 30122094
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anemarsaponin BII inhibits the activity of CYP3A4, 2D6, and 2E1 with human liver microsomes.
    Wang M; Jiang W; Zhou J; Xue X; Yin C
    Pharm Biol; 2020 Dec; 58(1):1064-1069. PubMed ID: 33103940
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mechanism-based inhibition of Alantolactone on human cytochrome P450 3A4 in vitro and activity of hepatic cytochrome P450 in mice.
    Qin CZ; Lv QL; Wu NY; Cheng L; Chu YC; Chu TY; Hu L; Cheng Y; Zhang X; Zhou HH
    J Ethnopharmacol; 2015 Jun; 168():146-9. PubMed ID: 25858508
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of In Vitro Cytochrome P450 Inhibition and In Vitro Fate of Structurally Diverse N-Oxide Metabolites: Case Studies with Clozapine, Levofloxacin, Roflumilast, Voriconazole and Zopiclone.
    Giri P; Naidu S; Patel N; Patel H; Srinivas NR
    Eur J Drug Metab Pharmacokinet; 2017 Aug; 42(4):677-688. PubMed ID: 27853934
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis of sulfaphenazole derivatives and their use as inhibitors and tools for comparing the active sites of human liver cytochromes P450 of the 2C subfamily.
    Ha-Duong NT; Dijols S; Marques-Soares C; Minoletti C; Dansette PM; Mansuy D
    J Med Chem; 2001 Oct; 44(22):3622-31. PubMed ID: 11606127
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enantioselectivity of inhibition of cytochrome P450 3A4 (CYP3A4) by ketoconazole: Testosterone and methadone as substrates.
    Dilmaghanian S; Gerber JG; Filler SG; Sanchez A; Gal J
    Chirality; 2004 Feb; 16(2):79-85. PubMed ID: 14712470
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Azoles, allylamines and drug metabolism.
    Back DJ; Tjia JF; Abel SM
    Br J Dermatol; 1992 Feb; 126 Suppl 39():14-8. PubMed ID: 1311943
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.